The , published in October 2020 by the Pharmaceutical Press , is the world's most authoritative resource for data on the physical properties, safe use, and applications of pharmaceutical excipients. Core Updates in the 9th Edition
: Five new chapters provide support on specialized topics:
: Classification of excipients by role.
The 9th edition has been meticulously updated to reflect the evolving regulatory landscape and the latest scientific advancements in pharmaceutical technology. Key features include: handbook of pharmaceutical excipients edition 9 pdf
: List of primary uses (e.g., binder, lubricant).
Pharmaceutical labs are high-value targets. A PDF downloaded from an unknown tracker could contain embedded scripts, ransomware, or keyloggers. In 2022, security firms reported a 350% increase in malicious PDFs disguised as technical handbooks.
: Includes data on solubility, melting points, and flowability to aid in manufacturing. The , published in October 2020 by the
Published jointly by the American Pharmacists Association (APhA) and the Pharmaceutical Press (the publishing division of the Royal Pharmaceutical Society), this handbook is a comprehensive guide to the physical, chemical, and functional properties of excipients.
Enhanced focus on safety profiles to aid in risk assessment during formulation development.
: Detailed descriptions of how the excipient behaves (e.g., binder, diluent, disintegrant, coating agent). Key features include: : List of primary uses (e
Jointly published by the and the Pharmaceutical Press (the publishing arm of the Royal Pharmaceutical Society), this handbook is a compilation of monographs on over 400 excipients.
The (published October 2020) is the world's most authoritative resource for information on the uses, properties, and safety of pharmaceutical excipients. It is widely used by pharmaceutical scientists involved in the development, production, and regulation of drug products. Key Features and Updates
: Updated toxicology profiles reflecting recent European Medicines Agency (EMA) and US Food and Drug Administration (FDA) guidelines.
Synonyms used across global markets (USP, Ph.Eur., JP).
: Expanded information on excipients used in biological drug delivery and vaccines.